Area of research
Endocrinology, Diabetes and Metabolism · Genetics
Research interest
Research interests include Diabetes Management and Research, Diabetes Treatment and Management, Hyperglycemia and glycemic control in critically ill and hospitalized patients, and Diabetes and associated disorders.
Clinical Impact of Continuous Glucose Monitoring in Noninsulin Treated Type 2 Diabetes: A Review
GLP-1RA Use and Thyroid Cancer Risk
Use of continuous glucose monitoring and point-of-care glucose testing in hospitalized patients with diabetes mellitus in non-intensive care unit settings: A systematic review and meta-analysis of randomized controlled trials
Moving Beyond Glycated Hemoglobin to Glucose Patterns: Newer Indications for Continuous Glucose Monitor Use
Prescribing Trends of Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes or Obesity
Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technology
Continuous Glucose Monitoring Improves Detection of Glycemic Excursions in Hemodialysis Patients With Type 2 Diabetes
Comparative effectiveness of GLP-1 receptor agonists on cardiovascular outcomes among adults with type 2 diabetes and moderate cardiovascular risk: emulation of a target trial
Improvement in body mass index category was associated with improved cardiometabolic measures and patient‐reported outcomes in adults with type 2 diabetes treated with tirzepatide
Risk of Sight-Threatening Diabetic Retinopathy with Glucagon-Like Peptide-1 Receptor Agonist Use in Routine Clinical Practice
Addressing the Diabetes Tsunami Requires Expanded Access to Diabetes Technologies
Wearable Diabetes Technology for Hospitalized People With Diabetes and End-Stage Kidney Disease, Peripartum State, and Steroid Use
Hyperglycemic Crises in Adults With Diabetes: A Consensus Report
Hyperglycaemic crises in adults with diabetes: a consensus report
Risks of peri‐ and <scp>postoperative</scp> complications with glucagon‐like peptide‐1 receptor agonists
The Diabetes Technology Society Error Grid and Trend Accuracy Matrix for Glucose Monitors
Continuous Glucose Monitoring for Prediabetes: What Are the Best Metrics?
Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular risk
Consensus Report on the Use of Continuous Glucose Monitoring in Chronic Kidney Disease and Diabetes
Comparative Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas for Sight-Threatening Diabetic Retinopathy
Diabetes technology in people with diabetes and advanced chronic kidney disease
Derivation of an Annualized Claims-Based Major Adverse Cardiovascular Event Estimator in Type 2 Diabetes
Diabetes Technology in People with Type 2 Diabetes: Novel Indications
Should We Stop Glucagon-Like Peptide-1 Receptor Agonists Before Surgical or Endoscopic Procedures? Balancing Limited Evidence With Clinical Judgment
Early-Onset Type 2 Diabetes and Tirzepatide Treatment: A Post Hoc Analysis From the SURPASS Clinical Trial Program
Randomized Study Comparing Continuous Glucose Monitoring and Capillary Glucose Testing in Patients With Type 2 Diabetes After Hospital Discharge
Continuous Glucose Monitoring Metrics and Hemoglobin A1c Relationship in Patients with Type 2 Diabetes Treated by Hemodialysis
Kidney Outcomes with Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes and Moderate Cardiovascular Risk
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm – 2023 Update